Clinical Trials in Houston

Showing 3381-3400 of 15,366 trials

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

NCT04857372

The purpose of this study is to characterize the safety and tolerability of IAG933 in patients with mesothelioma, NF2/LATS1/LATS2 mutated tumors and tumors with functional YAP/TAZ fusions and to identify the maximum tolerated dose and/or recommended dose.

Mesothelioma

Novartis Pharmaceuticals137 participantsStarted Oct 2021

Los Angeles, California, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +13 more locations

RECRUITINGPhase 2< 1 mile

Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

NCT03339128

The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating irritable bowel syndrome with diarrhea (IBS-D) in pediatric participants 6-17 years of age, to evaluate the pharmacokinetics of eluxadoline in pediatric participants with IBS-D, and to evaluate the safety and tolerability of eluxadoline in pediatric participants with IBS-D. Enrollment of 12-17 years old age group is closed, enrollment of the 6-11 years old age group will continue.

Irritable Bowel Syndrome

AbbVie95 participantsStarted Nov 2017

Hot Springs, Arkansas, United States • Little Rock, Arkansas, United States • Corona, California, United States +43 more locations

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

Find Trials by Condition in Houston

A Study of Auxora in Patients With Severe COVID-19 Pneumonia

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

Systematic Light Exposure in Pediatric Brain Tumor Survivors

Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules

Role of L-citrulline in Prevention of Pregnancy Associated Hypertension

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects

Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)

Clinical Procedures to Support Research in ALS

A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord (TTAX03) for KL Grade 3-4 Knee OA

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS

NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients

HLA Demographics Study in Adults With Type 1 Diabetes

Short-course Regimens for the Treatment of Pulmonary Tuberculosis